The NHS is embarking on a trial that could cut prostate cancer diagnosis times from weeks to a single day. The initiative ...
In the month of October, many organizations use the color pink to raise awareness for breast cancer. Women are encouraged to do regular home exams and to attend their annual mammograms. For men, ...
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong ...
Novartis acquires Avidity Biosciences for $12B to boost growth and rare disease pipeline. Explore impacts, risks, and outlook.
In the most talked-about film from the final year of the 20th century, "The Matrix," a computer hacker named Neo finds that ...
COLUMBIA, S.C. — Prostate cancer is the second leading cause of cancer deaths in men, according to the South Carolina Department of Public Health. Now, a special legislative committee is exploring ...
The technology that has helped propel the simulation theory may be new, but the questions it explores are ancient.
SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.
BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...
Researchers at IURES 2025 report seminal vesicle sampling enhances diagnostic accuracy in transperineal prostate biopsies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback